(-0.28%) 5 052.75 points
(-0.11%) 37 953 points
(-0.56%) 17 474 points
(-1.31%) $80.86
(-2.66%) $1.938
(-0.33%) $2 295.40
(0.04%) $26.67
(-0.08%) $947.40
(0.05%) $0.938
(0.24%) $11.12
(0.05%) $0.801
(0.03%) $93.48
-1.16% $ 7.67
Live Chart Being Loaded With Signals
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases...
Stats | |
---|---|
Dzisiejszy wolumen | 92 519.00 |
Średni wolumen | 75 375.00 |
Kapitalizacja rynkowa | 233.56M |
EPS | $-0.420 ( 2024-03-13 ) |
Następna data zysków | ( $0 ) 2024-05-08 |
Last Dividend | $2.50 ( 2021-07-15 ) |
Next Dividend | $0 ( N/A ) |
P/E | -9.47 |
ATR14 | $0.0350 (0.46%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-03 | Simard John | Buy | 2 470 355 | Convertible Loan Agreement |
2023-06-23 | Waldin Jan-paul | Buy | 25 000 | Director Stock Option |
2023-06-23 | Libby Peter | Buy | 25 000 | Director Stock Option |
2023-06-23 | Macadam Donald H. | Buy | 25 000 | Director Stock Option |
2023-06-23 | Mckenzie W Thorpe | Buy | 25 000 | Director Stock Option |
INSIDER POWER |
---|
97.98 |
Last 100 transactions |
Buy: 4 116 188 | Sell: 11 979 897 |
Wolumen Korelacja
XBiotech Inc Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
VVOS | 0.88 |
BPRN | 0.871 |
BELFA | 0.856 |
CGO | 0.845 |
CNTY | 0.845 |
PASG | 0.84 |
APLD | 0.838 |
DORM | 0.831 |
BBCP | 0.815 |
ATNX | 0.812 |
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
XBiotech Inc Korelacja - Waluta/Towar
XBiotech Inc Finanse
Annual | 2023 |
Przychody: | $0 |
Zysk brutto: | $-1.74M (0.00 %) |
EPS: | $-0.810 |
FY | 2023 |
Przychody: | $0 |
Zysk brutto: | $-1.74M (0.00 %) |
EPS: | $-0.810 |
FY | 2022 |
Przychody: | $4.01M |
Zysk brutto: | $3.36M (83.77 %) |
EPS: | $-1.080 |
FY | 2021 |
Przychody: | $18.39M |
Zysk brutto: | $12.57M (68.36 %) |
EPS: | $-0.580 |
Financial Reports:
No articles found.
XBiotech Inc Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $2.50 | 2021-07-15 |
Last Dividend | $2.50 | 2021-07-15 |
Next Dividend | $0 | N/A |
Payout Date | 2021-07-23 | |
Next Payout Date | N/A | |
# dividends | 1 | -- |
Total Paid Out | $2.50 | -- |
Avg. Dividend % Per Year | 1.55% | -- |
Score | 0.63 | -- |
Div. Sustainability Score | 0 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 0 | -- |
Year | Amount | Yield |
---|---|---|
2021 | $2.50 | 15.50% |
2022 | $0 | 0.00% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -9.37 | 1.500 | -10.00 | -10.00 | [0 - 0.5] |
returnOnAssetsTTM | -0.108 | 1.200 | -3.60 | -4.32 | [0 - 0.3] |
returnOnEquityTTM | -0.108 | 1.500 | -2.31 | -3.47 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 33.07 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 32.94 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 32.79 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 0 | 1.000 | -1.111 | -1.111 | [3 - 30] |
operatingCashFlowPerShareTTM | -0.615 | 2.00 | -0.205 | -0.410 | [0 - 30] |
freeCashFlowPerShareTTM | -0.627 | 2.00 | -0.314 | -0.627 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.334 | 1.000 | 7.76 | 7.76 | [0.2 - 0.8] |
operatingProfitMarginTTM | -14.32 | 1.000 | -10.00 | -10.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0.0115 | 0.800 | -3.26 | -2.61 | [0.5 - 2] |
Total Score | -0.390 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -9.51 | 1.000 | -1.061 | 0 | [1 - 100] |
returnOnEquityTTM | -0.108 | 2.50 | -1.487 | -3.47 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -0.627 | 2.00 | -0.209 | -0.627 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -0.615 | 2.00 | -0.205 | -0.410 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -0.268 | 1.500 | -5.12 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | -7.15 | 1.000 | -10.00 | 0 | [0.1 - 0.5] |
Total Score | -2.33 |
XBiotech Inc
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation, and True Human COVID-19 therapy for treating the COVID-19 mutant virus. The company was incorporated in 2005 and is headquartered in Austin, Texas.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej